Recombinant Human Hemopexin/HPX Protein (His Tag)(Active)

Elabscience
Product Code: PKSH031380
Product Group: Recombinant Proteins
Supplier: Elabscience
CodeSizePrice
PKSH031380-100ug100ug£664.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)
Shipping:
This product is provided as lyophilized powder which is shipped with ice packs.
Storage:
Generally lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Images

1 / 1

Documents

Further Information

Abbreviation:
Hemopexin;HPX
Accession:
NP_000604.1
Activity:
Measured by its ability to bind protoporphyrin IX (PPPIX). Recombinant human Hemopexin binds > 10 uM PPPIX, resulting in a 50% decrease in the fluorescence signal of human Hemopexin.
Background:
Hemopexin (HPX) is plasma glycoprotein belongs to the family of the acute-phase proteins whose synthesis is induced after an inflammatory event. Hemopexin with two four-bladed beta -propeller folds has been found in other proteins including collagenases and provides sites for protein-protein interactions. The liver is the major synthesizing organ. Hemopexin participates in maintaining and recycling the iron pool by utilizing its high binding affinity toward heme composed of protoporphyrin IX and iron. It also functions in preventing oxidation caused by heme after hemolysis. Hydrophobic heme molecules can intercalate into lipid membranes and participate in the oxidation of lipid membrane components through the Fenton reaction resulting in lipid peroxidation. Hemopexin undergoes a conformational change upon the binding of heme. The conformational change allows hemopexin to interact with a specific receptor, forming a complex which is then internalized. Heme concentrations in plasma increase after hemolysis, which is associated with several pathological conditions such as reperfusion injury and ischemia.
Calculated MW:
50.7 kDa
Endotoxin:
< 1.0 EU per ug of the protein as determined by the LAL method.
Expression Host:
HEK293 Cells
Formulation:
Lyophilized from sterile PBS, pH 7.4
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Fusion tag:
C-His
ObservedMW:
70-75 kDa
Purity:
> 96 % as determined by reducing SDS-PAGE.
Sequence:
Met 1-His 462
Target Synonym:
Hemopexin;Hpx;Hpxn